These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 8557820

  • 1. Corticotropin-releasing hormone is involved in conditioned stimulus-induced reduction of natural killer cell activity but not in conditioned alterations in cytokine production or proliferation responses.
    Perez L, Lysle DT.
    J Neuroimmunol; 1995 Dec; 63(1):1-8. PubMed ID: 8557820
    [Abstract] [Full Text] [Related]

  • 2. Evidence for the involvement of beta-adrenergic receptors in conditioned immunomodulation.
    Luecken LJ, Lysle DT.
    J Neuroimmunol; 1992 Jun; 38(3):209-19. PubMed ID: 1351060
    [Abstract] [Full Text] [Related]

  • 3. Evidence for the involvement of macrophage-derived nitric oxide in the modulation of immune status by a conditioned aversive stimulus.
    Coussons-Read ME, Maslonek KA, Fecho K, Perez L, Lysle DT.
    J Neuroimmunol; 1994 Feb; 50(1):51-8. PubMed ID: 8300858
    [Abstract] [Full Text] [Related]

  • 4. Rat strains that differ in corticotropin-releasing hormone production exhibit different sleep-wake responses to interleukin 1.
    Opp MR, Imeri L.
    Neuroendocrinology; 2001 Apr; 73(4):272-84. PubMed ID: 11340341
    [Abstract] [Full Text] [Related]

  • 5. Modulation of immune status by a conditioned aversive stimulus: evidence for the involvement of endogenous opioids.
    Lysle DT, Luecken LJ, Maslonek KA.
    Brain Behav Immun; 1992 Jun; 6(2):179-88. PubMed ID: 1324030
    [Abstract] [Full Text] [Related]

  • 6. Conditioned immunomodulation: investigations of the role of endogenous activity at mu, kappa, and delta opioid receptor subtypes.
    Perez L, Lysle DT.
    J Neuroimmunol; 1997 Nov; 79(2):101-12. PubMed ID: 9394782
    [Abstract] [Full Text] [Related]

  • 7. Intermittent but not continuous inescapable footshock stress affects immune responses and immunocyte beta-endorphin concentrations in the rat.
    Sacerdote P, Manfredi B, Bianchi M, Panerai AE.
    Brain Behav Immun; 1994 Sep; 8(3):251-60. PubMed ID: 7865896
    [Abstract] [Full Text] [Related]

  • 8. The role of central corticotropin-releasing hormone in the anorexic and endocrine effects of the bacterial T cell superantigen, Staphylococcal enterotoxin A.
    Kaneta T, Kusnecov AW.
    Brain Behav Immun; 2005 Mar; 19(2):138-46. PubMed ID: 15664786
    [Abstract] [Full Text] [Related]

  • 9. Endogenous corticotropin-releasing hormone inhibits conditioned-fear-induced vagal activation in the rat.
    Nijsen MJ, Croiset G, Diamant M, Stam R, Kamphuis PJ, Bruijnzeel A, de Wied D, Wiegant VM.
    Eur J Pharmacol; 2000 Feb 11; 389(1):89-98. PubMed ID: 10686300
    [Abstract] [Full Text] [Related]

  • 10. Long-term intracerebroventricular corticotropin-releasing hormone administration induces distinct changes in rat splenocyte activation and cytokine expression.
    Labeur MS, Arzt E, Wiegers GJ, Holsboer F, Reul JM.
    Endocrinology; 1995 Jun 11; 136(6):2678-88. PubMed ID: 7750492
    [Abstract] [Full Text] [Related]

  • 11. Brain corticotropin-releasing hormone- and interleukin-1 beta-induced suppression of specific antibody production.
    Irwin M.
    Endocrinology; 1993 Sep 11; 133(3):1352-60. PubMed ID: 8365372
    [Abstract] [Full Text] [Related]

  • 12. Benzodiazepines antagonize central corticotropin releasing hormone-induced suppression of natural killer cell activity.
    Irwin M, Hauger RL, Britton K.
    Brain Res; 1993 Dec 17; 631(1):114-8. PubMed ID: 8298983
    [Abstract] [Full Text] [Related]

  • 13. Central corticotropin-releasing factor suppresses natural killer cytotoxicity.
    Irwin MR, Vale W, Britton KT.
    Brain Behav Immun; 1987 Mar 17; 1(1):81-7. PubMed ID: 3502536
    [Abstract] [Full Text] [Related]

  • 14. Locus coeruleus stimulation by corticotropin-releasing hormone suppresses in vitro cellular immune responses.
    Rassnick S, Sved AF, Rabin BS.
    J Neurosci; 1994 Oct 17; 14(10):6033-40. PubMed ID: 7931560
    [Abstract] [Full Text] [Related]

  • 15. Fear-motivated behavior induced by prior shock experience is mediated by corticotropin-releasing hormone systems.
    Kalin NH, Takahashi LK.
    Brain Res; 1990 Feb 12; 509(1):80-4. PubMed ID: 2155045
    [Abstract] [Full Text] [Related]

  • 16. Involvement of central, but not placental corticotropin releasing hormone (CRH) in heat stress induced immunosuppression during pregnancy.
    Nakamura H, Nagase H, Ogino K, Hatta K, Matsuzaki I.
    Brain Behav Immun; 2001 Mar 12; 15(1):43-53. PubMed ID: 11259079
    [Abstract] [Full Text] [Related]

  • 17. The role of the locus coeruleus in corticotropin-releasing hormone and stress-induced suppression of pulsatile luteinizing hormone secretion in the female rat.
    Mitchell JC, Li XF, Breen L, Thalabard JC, O'Byrne KT.
    Endocrinology; 2005 Jan 12; 146(1):323-31. PubMed ID: 15486230
    [Abstract] [Full Text] [Related]

  • 18. High intracerebral levels of CRH result in CRH receptor downregulation in the amygdala and neuroimmune desensitization.
    Hauger RL, Irwin MR, Lorang M, Aguilera G, Brown MR.
    Brain Res; 1993 Jul 09; 616(1-2):283-92. PubMed ID: 8395304
    [Abstract] [Full Text] [Related]

  • 19. Pavlovian conditioning of morphine-induced alterations of immune status: evidence for opioid receptor involvement.
    Coussons-Read ME, Dykstra LA, Lysle DT.
    J Neuroimmunol; 1994 Dec 09; 55(2):135-42. PubMed ID: 7829663
    [Abstract] [Full Text] [Related]

  • 20. Brain vasopressin is involved in stress-induced suppression of immune function in the rat.
    Shibasaki T, Hotta M, Sugihara H, Wakabayashi I.
    Brain Res; 1998 Oct 12; 808(1):84-92. PubMed ID: 9795154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.